BCL2 and diffuse large B-cell lymphoma: In our study, DLBCL patients with Bcl-2+/Bcl-6- progressed rapidly and had short survival time when they received CHOP regimen, but had relatively longer PFS and OS when received T-CHOP regimen (Figure 3).